Tumor Biology

, Volume 31, Issue 5, pp 489–493 | Cite as

The GSTT1 polymorphism of the glutathione S-transferase system in the intratumoral microvessel density of breast cancer patients

  • Gustavo J. Lourenço
  • André A. Schenka
  • Cassio Cardoso-Filho
  • Glauce A. Pinto
  • Maria S. Costa-Gurgel
  • José Vassallo
  • Carmen Silvia Passos Lima
Research Article


It is well established that hypoxic microenvironment contributes to breast cancer progression by activation of transcriptional genes that promote angiogenesis. By promoting the antioxidant activity of glutathione, glutathione S-transferases (GSTs) are likely to facilitate the hypoxia-inducible factor-1α (HIF-1α) activity, therefore stimulating the angiogenesis. We investigated herein the influence of the GSTM1 and GSTT1 polymorphisms in the intratumoral angiogenesis of 87 patients with sporadic breast cancer. The intratumoral microvessel density (IMVD) of formalin-fixed paraffin-embedded tissues samples from all patients was determined by immunohistochemistry. The high IMVD was defined as a median microvessel counting higher than 18.7 after the analysis of histogram with all the results. The high IMVD was more common in patients with the GSTT1 wild genotype than in those with the GSTT1 null genotype (P = 0.04). Our results suggest, for the first time, that the GSTT1 polymorphism constitutes an inherited determinant of intratumoral angiogenesis in sporadic breast cancer.


GSTM1 GSTT1 Angiogenesis Breast cancer 



This work was supported by Fundação de Apoio à Pesquisa do Estado de São Paulo (FAPESP).

Conflicts of interests

The authors declare that they have no competing interests.

Authors’ contributions

G.J.L. and C.S.P.L. conceived and participated in all steps of the study. G.A.P. performed and processed the immunohistochemical experiments. A.A.S. and J.V. participated in the analysis of immunohistochemical data, in statistical analysis and discussion of the results. C.C.F. and M.S.C.G. performed the clinical evaluation of the patients. All authors read and approved the final version of the manuscript.


  1. 1.
    Folkman J. Angiogenesis and breast cancer. J Clin Oncol. 1994;12(3):441–3.PubMedGoogle Scholar
  2. 2.
    Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007;129(3):465–72.CrossRefPubMedGoogle Scholar
  3. 3.
    Bicknell R, Harris AL. Novel angiogenic signalling pathways and vascular targets. Annu Rev Pharmacol Toxicol. 2004;44:219–38.CrossRefPubMedGoogle Scholar
  4. 4.
    Haddad JJ, Olver RE, Land SC. Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem. 2004;275(28):21130–9.CrossRefGoogle Scholar
  5. 5.
    El-Sharabasy MM, el-Dosoky I, Horria H, Khalaf AH. Elevation of glutathione, glutathione-reductase and nucleic acids in both normal tissues and tumour of breast cancer patients. Cancer Lett. 1993;72(1–2):11–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Mallery SR, Lantry LE, Laufman HB, Stephens RE, Brierley GP. Modulation of human microvascular endothelial cell bioenergetic status and glutathione levels during proliferative and differentiated growth. J Cell Biochem. 1993;53(4):360–72.CrossRefPubMedGoogle Scholar
  7. 7.
    Perry RR, Mazetta JA, Levin M, Barranco SC. Glutathione levels and variability in breast tumors and normal tissue. Cancer. 1993;72(3):783–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Gromadzinska J, Wasowicz W, Andrijewski M, Skłodowska M, Quispe OZ, Wołkanin P, et al. Glutathione and glutathione metabolizing enzymes in tissues and blood of breast cancer patients. Neoplasma. 1997;44(1):45–51.PubMedGoogle Scholar
  9. 9.
    Kumaraguruparan R, Subapriya R, Viswanathan P, Nagini S. Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. Clin Chim Acta. 2002;325(1–2):165–70.CrossRefPubMedGoogle Scholar
  10. 10.
    Kumaraguruparan R, Kabalimoorthy J, Nagini S. Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem. 2005;38(2):154–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Uzzan B, Nicolas P, Cucherat M, Perret GY. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analyses. Cancer Res. 2004;64:2941–55.CrossRefPubMedGoogle Scholar
  12. 12.
    Coles BF, Kadlubar FF. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors. 2003;17(1–4):115–30.CrossRefPubMedGoogle Scholar
  13. 13.
    Medeiros R, Soares R, Vasconcelos A, Vasconcelos A, Schmitt F, Lopes C. Glutathione S-transferase genotype GSTM1 as a predictor of elevated angiogenic phenotype in patients with early onset breast cancer. Angiogenesis. 2004;7(1):53–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. Breast. In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002. p. 223–40.Google Scholar
  15. 15.
    Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403–10.CrossRefPubMedGoogle Scholar
  16. 16.
    Woodhead JL, Fallon R, Figuered H, Longdale J, Malcom AD. Alternative methodology of gene diagnosis. In: Davies KE, editor. Human genetic diseases—a practical approach. Oxford: IRL; 1986. p. 51–64.Google Scholar
  17. 17.
    Arruda VR, Lima CS, Grignoli CR, de Melo MB, Lorand-Metze I, Alberto FL, et al. Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur J Haematol. 2001;66(6):383–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Alves-Silva J, da Silva-Santos M, Guimarães PE, Ferreira AC, Bandelt HJ, Pena SD. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet. 2000;67:444–61.CrossRefPubMedGoogle Scholar
  19. 19.
    Carvalho-Silva DR, Santos FR, Rocha J, Pena SD. The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet. 2001;68:281–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, et al. Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS ONE. 2009;4(2):e4531.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2010

Authors and Affiliations

  • Gustavo J. Lourenço
    • 1
  • André A. Schenka
    • 2
  • Cassio Cardoso-Filho
    • 3
  • Glauce A. Pinto
    • 3
  • Maria S. Costa-Gurgel
    • 3
  • José Vassallo
    • 2
  • Carmen Silvia Passos Lima
    • 1
  1. 1.Department of Internal Medicine, Faculty of Medical SciencesState University of CampinasCampinasBrazil
  2. 2.Department of Pathology, Faculty of Medical SciencesState University of CampinasCampinasBrazil
  3. 3.Department of Obstetric and Gynaecology, Faculty of Medical SciencesState University of CampinasCampinasBrazil

Personalised recommendations